Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?

(2009) Rhiannon C. Macefield et al.   EUROPEAN JOURNAL OF CANCER

European Association of Urology Position Statement on Screening for Prostate Cancer

(2009) Per-Anders Abrahamsson et al.   EUROPEAN UROLOGY

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?

(2008) Kerry N.L. Avery et al.   BJU INTERNATIONAL

Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study

(2008) Simon M Collin et al.   LANCET ONCOLOGY

The measurement of psychological distress in men being investigated for the presence of prostate cancer

(2008) N S Awsare et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Decision-Making about PSA Testing and Prostate Biopsies: A Qualitative Study Embedded in a Primary Care Randomised Trial

(2007) Kerry N.L. Avery et al.   EUROPEAN UROLOGY

Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study

(2007) Derek J. Rosario et al.   EUROPEAN UROLOGY